JNJ-10181457 also demonstrated normalization of ACh neurotransmission in the rat cortex, which indicates that selective H3R non-imidazole antagonists may be very effective in conditions with decreased levels of ACh release commonly found in cognitive disorders such as AD, dementia, ASD, and SCH. Here, HRH3 is linked to Cognitive impairment.